OCTAPHARMA Trademark

Trademark Overview

On Thursday, September 20, 2001, a trademark application was filed for OCTAPHARMA with the United States Patent and Trademark Office. The USPTO has given the OCTAPHARMA trademark a serial number of 76314715. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 9, 2015. This trademark is owned by Octapharma AG. The OCTAPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely blood plasma derivatives in the nature of virus inactivated blood plasma, blood clotting factors, immunoglobulins
octapharma

General Information

Serial Number76314715
Word MarkOCTAPHARMA
Filing DateThursday, September 20, 2001
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 9, 2015
Registration Number2938519
Registration DateTuesday, April 5, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 10, 2002

Trademark Statements

Goods and ServicesPharmaceutical products, namely blood plasma derivatives in the nature of virus inactivated blood plasma, blood clotting factors, immunoglobulins

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 2, 2001
Primary Code005
First Use Anywhere DateWednesday, June 30, 2004
First Use In Commerce DateWednesday, June 30, 2004

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLachen CH-8853
CH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLachen CH-8853
CH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLachen CH-8853
CH

Trademark Events

Event DateEvent Description
Friday, April 5, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, April 9, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, April 9, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 9, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 9, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 26, 2015TEAS SECTION 8 & 9 RECEIVED
Tuesday, April 12, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 12, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 4, 2011TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 5, 2005REGISTERED-PRINCIPAL REGISTER
Monday, January 3, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, December 30, 2004ASSIGNED TO LIE
Wednesday, December 22, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 22, 2004STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 22, 2004SOU EXTENSION 4 GRANTED
Friday, December 3, 2004USE AMENDMENT FILED
Friday, December 3, 2004SOU EXTENSION 4 FILED
Friday, December 3, 2004PAPER RECEIVED
Friday, June 25, 2004SOU EXTENSION 3 GRANTED
Thursday, June 3, 2004SOU EXTENSION 3 FILED
Tuesday, June 15, 2004CASE FILE IN TICRS
Thursday, June 3, 2004PAPER RECEIVED
Monday, April 26, 2004ASSIGNED TO EXAMINER
Wednesday, January 7, 2004SOU EXTENSION 2 GRANTED
Wednesday, December 3, 2003SOU EXTENSION 2 FILED
Wednesday, December 3, 2003PAPER RECEIVED
Thursday, June 26, 2003SOU EXTENSION 1 GRANTED
Thursday, May 29, 2003SOU EXTENSION 1 FILED
Thursday, May 29, 2003PAPER RECEIVED
Tuesday, December 3, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2002PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2002NOTICE OF PUBLICATION
Wednesday, May 29, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 18, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 27, 2001NON-FINAL ACTION MAILED
Tuesday, November 20, 2001ASSIGNED TO EXAMINER

Related Keywords

octapharma blood plasma clotting inactivated virus factors immunoglobulins derivatives products namely